Delivery Order SPE2DB22D2007-SPE2DB25FJ0WN
Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,892.67 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100-count units) under a firm fixed-price contract. The award was issued on March 11, 2025, with an ultimate completion date of March 12, 2025, and represents a non-set-aside competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,571.30 to AmerisourceBergen Drug Corp for the supply of Vyvanse 10 mg capsules (100-count units) under a firm fixed-price contract. The award was made competitively with no set-aside designation and carries an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in the same municipality. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,437.80 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100 count) on August 7, 2025, with completion scheduled for August 8, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $3,684.38 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This competitively awarded contract, with no set-aside designation, is classified as a firm fixed price delivery order with performance completion scheduled for August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $1,679.97 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $2,943.88. This is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 7, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $3,599.13. This competitive, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 10 mg capsules (100-count units) valued at $4,418.55. This competitively awarded, non-set-aside contract is classified as a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under the...
- The Defense Logistics Agency awarded a $11,625.10 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Vyvanse 10 mg capsules (100-count units). This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,205.48 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100-count units) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader Indefinite Delivery...